| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |